THURSDAY, Jan. 2, 2024 (HealthDay News) — Weight loss tops many folks’ list of New Years resolutions, and lots of people are turning to cutting-edge weight-loss drugs like Ozempic to help them drop excess pounds. These drugs, called glucagon-like peptide-1 receptor agonists (GLP-1 RAs), work in several different ways toContinue Reading
TUESDAY, Dec. 10, 2024 (HealthDay News) — People with diabetes who are taking GLP-1 meds such as Ozempic or Mounjaro may be getting an added bonus: Reductions in their odds for a dangerous blood clot, new research finds. The study found that folks with diabetes who were using the drugsContinue Reading
THURSDAY, Dec. 5, 2024 (HealthDay News) — The choice may be bittersweet, but the evidence is clear: New research shows that dark chocolate can lower a person’s risk of type 2 diabetes. People who ate at least five servings of dark chocolate a week had a 21% lower risk ofContinue Reading
WEDNESDAY, Dec. 4, 2024 (HealthDay News) — Taking even high doses of supplementary vitamin D won’t lower an older person’s odds for type 2 diabetes, new research confirms. Vitamin D supplements may have other benefits, but in otherwise healthy folks with sufficient levels of the nutrient, “our findings do notContinue Reading
WEDNESDAY, Nov. 27, 2024 (HealthDay News) — The cutting-edge weight-loss drug Zepbound can protect obese people from developing type 2 diabetes, a new clinical trial has found. Zepbound reduced the risk of diabetes in obese prediabetic patients by more than 90% during a three-year period compared to placebo, trial resultsContinue Reading
WEDNESDAY, Nov. 27, 2024 (HealthDay News) — Already the go-to drug of choice for millions with type 2 diabetes, metformin might also fight lung cancer if those patients have it as well, new research shows. Metformin appears to help boost the benefits of immunotherapy drugs used to fight lung tumors,Continue Reading
-690x550.jpg)
FRIDAY, Nov. 22, 2024 (HealthDay News) — How long Americans can expect to live varies dramatically — and the gap continues to widen. A new report says health inequalities have, in essence, created 10 Americas. These mutually exclusive populations are divided along familiar fault lines, including race, ethnicity, income andContinue Reading
WEDNESDAY, Nov. 20, 2024 (HealthDay News) — A type 2 diabetes diagnosis before age 50 comes with a health risk that patients might not expect. Especially if they are obese, these folks are more likely to develop dementia later, new research warns. “Our study suggests that there may be a cognitiveContinue Reading
MONDAY, Nov. 18, 2024 (HealthDay News) — Drugs already taken by millions of diabetes patients appear to also help slash asthma attacks by up to 70%, new British research shows. The two drugs are metformin, one of the most widely used diabetes medications, and the GLP-1 class of medications thatContinue Reading
THURSDAY, Nov. 14, 2024 (HealthDay News) — Fourteen percent of the world’s people — more than 800 million — now have diabetes, a doubling of the global rate for the blood sugar disease since 1990, new statistics show. Type 2 diabetes, which makes up 95% of cases, is surging inContinue Reading